Drury AN, Szent-Gyorgyi A.The physiological activity of adenosine compounds with special reference to their action upon the mammalian heart. J Physiol.1929;68:213-237.
2.
Overholt ED, Rhueban KS, Gutgesell HP, et al. Usefulness of adenosine for arrhythmias in infants and children . Am J Cardiol.1988;61:333-340.
3.
Rossi AF, Burton DAAdenosine in altering short- and long-term treatment of supraventricular tachycardia in infants. Am J Cardiol.1989;64:685-686.
4.
Clarke B., Till J., Rowland E., et al. Rapid and safe termination of supraventricular tachycardia in children by adenosine. Lancet. 1987;1:299-301.
5.
Till J., Shinebourne EA, Rigby ML, et al. Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children. Br Heart J.1989;62:204-211.
6.
Garrett CJ, Linker NJ, Griffith MJ, et al. Comparison of adenosine and verapamil for termination of paroxysmal supraventricular tachycardia. Am J Cardiol.1989;64:1310-1316.
7.
DiMarco JP, Miles W., Akhtar M., et al. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials: the Adenosine for PSVT Study Group. Ann Intern Med.1990;113:104-110.
8.
Camm AJ, Garratt CJAdenosine and supraventricular tachycardia. N Engl J Med.1991;325:1621-1629.
Smits P., Lenders JW, Thien T.Caffeine and theophylline attenuate adenosine-induced vasodilation in humans . Clin Pharmacol Ther.1990;48:410-418.
11.
Rankin AC, Oldroyd KG, Chong E., et al. Adenosine or adenosine triphosphate for supraventricular tachycardias ? Comparative double-blind randomized study in patients with spontaneous or inducible arrhythmias. Am Heart J.1990;119:316-323.
